Committee on Rules of Practice and Procedure; Meeting of the Judicial Conference, 25698 [2023-08943]
Download as PDF
<![CDATA[
25698
Federal Register / Vol. 88, No. 81 / Thursday, April 27, 2023 / Notices
INTERNATIONAL TRADE
COMMISSION
[USITC SE–23–021]
Sunshine Act Meetings
United
States International Trade Commission.
TIME AND DATE: May 4, 2023 at 11:00
a.m.
PLACE: Room 101, 500 E Street SW,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: none.
2. Minutes.
3. Ratification List.
4. Commission vote on Inv. No. 731–
TA–683 (Fifth Review)(Fresh Garlic
from China). The Commission currently
is scheduled to complete and file its
determinations and views of the
Commission on May 12, 2023.
5. Outstanding action jackets: none.
CONTACT PERSON FOR MORE INFORMATION:
Sharon Bellamy, Acting Hearings and
Information Officer, 202–205–2000.
The Commission is holding the
meeting under the Government in the
Sunshine Act, 5 U.S.C. 552(b). In
accordance with Commission policy,
subject matter listed above, not disposed
of at the scheduled meeting, may be
carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
By order of the Commission.
Issued: April 25, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–09074 Filed 4–25–23; 4:15 pm]
BILLING CODE 7020–02–P
JUDICIAL CONFERENCE OF THE
UNITED STATES
Committee on Rules of Practice and
Procedure; Meeting of the Judicial
Conference
Judicial Conference of the
United States.
ACTION: Committee on Rules of Practice
and Procedure; notice of open meeting.
AGENCY:
The Committee on Rules of
Practice and Procedure will hold a
meeting in a hybrid format with remote
attendance options on June 6, 2023 in
Washington, DC. The meeting is open to
the public for observation but not
participation. An agenda and supporting
materials will be posted at least 7 days
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:49 Apr 26, 2023
Jkt 259001
in advance of the meeting at: https://
www.uscourts.gov/rules-policies/
records-and-archives-rules-committees/
agenda-books.
DATES: June 6, 2023.
FOR FURTHER INFORMATION CONTACT: H.
Thomas Byron III, Esq., Chief Counsel,
Rules Committee Staff, Administrative
Office of the U.S. Courts, Thurgood
Marshall Federal Judiciary Building,
One Columbus Circle NE, Suite 7–300,
Washington, DC 20544, Phone (202)
502–1820, RulesCommittee_Secretary@
ao.uscourts.gov.
(Authority: 28 U.S.C. 2073.)
Dated: April 24, 2023.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
[FR Doc. 2023–08943 Filed 4–26–23; 8:45 am]
BILLING CODE 2210–55–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1187]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Royal
Dynastic Organics
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before June 26, 2023.
ADDRESSES: DEA requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
SUMMARY:
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.’’
The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
submit electronic comments on or
objections of the requested registration,
as provided in this notice. This notice
does not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on March 8, 2023, Royal Dynastic
Organics, 865 Hogbin Road, Millville,
New Jersey 08332–7608, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\27APN1.SGM
27APN1
]]>Agencies
[Federal Register Volume 88, Number 81 (Thursday, April 27, 2023)]
[Notices]
[Page 25698]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-08943]
=======================================================================
-----------------------------------------------------------------------
JUDICIAL CONFERENCE OF THE UNITED STATES
Committee on Rules of Practice and Procedure; Meeting of the
Judicial Conference
AGENCY: Judicial Conference of the United States.
ACTION: Committee on Rules of Practice and Procedure; notice of open
meeting.
-----------------------------------------------------------------------
SUMMARY: The Committee on Rules of Practice and Procedure will hold a
meeting in a hybrid format with remote attendance options on June 6,
2023 in Washington, DC. The meeting is open to the public for
observation but not participation. An agenda and supporting materials
will be posted at least 7 days in advance of the meeting at: https://www.uscourts.gov/rules-policies/records-and-archives-rules-committees/agenda-books.
DATES: June 6, 2023.
FOR FURTHER INFORMATION CONTACT: H. Thomas Byron III, Esq., Chief
Counsel, Rules Committee Staff, Administrative Office of the U.S.
Courts, Thurgood Marshall Federal Judiciary Building, One Columbus
Circle NE, Suite 7-300, Washington, DC 20544, Phone (202) 502-1820,
[email protected].
(Authority: 28 U.S.C. 2073.)
Dated: April 24, 2023.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
[FR Doc. 2023-08943 Filed 4-26-23; 8:45 am]
BILLING CODE 2210-55-P
